Thembaninkosi G Gaule1, Mark A Smith1, Katarzyna M Tych1,2, Pascale Pirrat1, Chi H Trinh1, Arwen R Pearson1,3, Peter F Knowles1, Michael J McPherson1. 1. Astbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, Faculty of Biological Sciences , University of Leeds , Leeds LS2 9JT , U.K. 2. Physik-Department, Lehrstuhl für Biophysik E22 , Technische Universität München , D-85748 Garching , Germany. 3. Hamburg Centre of Ultrafast Imaging and Institute for Nanostructure and Solid State Physics , Universität Hamburg , D-22761 Hamburg , Germany.
Abstract
Copper amine oxidases (CuAOs) are metalloenzymes that reduce molecular oxygen to hydrogen peroxide during catalytic turnover of primary amines. In addition to Cu2+ in the active site, two peripheral calcium sites, ∼32 Å from the active site, have roles in Escherichia coli amine oxidase (ECAO). The buried Ca2+ (Asp533, Leu534, Asp535, Asp678, and Ala679) is essential for full-length protein production, while the surface Ca2+ (Glu573, Tyr667, Asp670, and Glu672) modulates biogenesis of the 2,4,5-trihydroxyphenylalanine quinone (TPQ) cofactor. The E573Q mutation at the surface site prevents calcium binding and TPQ biogenesis. However, TPQ biogenesis can be restored by a suppressor mutation (I342F) in the proposed oxygen delivery channel to the active site. While supporting TPQ biogenesis (∼60% WTECAO TPQ), I342F/E573Q has almost no amine oxidase activity (∼4.6% WTECAO activity). To understand how these long-range mutations have major effects on TPQ biogenesis and catalysis, we employed ultraviolet-visible spectroscopy, steady-state kinetics, inhibition assays, and X-ray crystallography. We show that the surface metal site controls the equilibrium (disproportionation) of the Cu2+-substrate reduced TPQ (TPQAMQ) Cu+-TPQ semiquinone (TPQSQ) couple. Removal of the calcium ion from this site by chelation or mutagenesis shifts the equilibrium to Cu2+-TPQAMQ or destabilizes Cu+-TPQSQ. Crystal structure analysis shows that TPQ biogenesis is stalled at deprotonation in the Cu2+-tyrosinate state. Our findings support WTECAO using the inner sphere electron transfer mechanism for oxygen reduction during catalysis, and while a Cu+-tyrosyl radical intermediate is not essential for TPQ biogenesis, it is required for efficient biogenesis.
Copper amine oxidases (CuAOs) are metalloenzymes that reduce molecular oxygen to hydrogen peroxide during catalytic turnover of primary amines. In addition to Cu2+ in the active site, two peripheral calcium sites, ∼32 Å from the active site, have roles in Escherichia coli amine oxidase (ECAO). The buried Ca2+ (Asp533, Leu534, Asp535, Asp678, and Ala679) is essential for full-length protein production, while the surface Ca2+ (Glu573, Tyr667, Asp670, and Glu672) modulates biogenesis of the 2,4,5-trihydroxyphenylalanine quinone (TPQ) cofactor. The E573Q mutation at the surface site prevents calcium binding and TPQ biogenesis. However, TPQ biogenesis can be restored by a suppressor mutation (I342F) in the proposed oxygen delivery channel to the active site. While supporting TPQ biogenesis (∼60% WTECAO TPQ), I342F/E573Q has almost no amine oxidase activity (∼4.6% WTECAO activity). To understand how these long-range mutations have major effects on TPQ biogenesis and catalysis, we employed ultraviolet-visible spectroscopy, steady-state kinetics, inhibition assays, and X-ray crystallography. We show that the surface metal site controls the equilibrium (disproportionation) of the Cu2+-substrate reduced TPQ (TPQAMQ) Cu+-TPQ semiquinone (TPQSQ) couple. Removal of the calcium ion from this site by chelation or mutagenesis shifts the equilibrium to Cu2+-TPQAMQ or destabilizes Cu+-TPQSQ. Crystal structure analysis shows that TPQ biogenesis is stalled at deprotonation in the Cu2+-tyrosinate state. Our findings support WTECAO using the inner sphere electron transfer mechanism for oxygen reduction during catalysis, and while a Cu+-tyrosyl radical intermediate is not essential for TPQ biogenesis, it is required for efficient biogenesis.
Copper amine
oxidases (CuAOs)
have important roles in many organisms and have been implicated in
a number of pathological conditions.[1−9] All CuAOs are homodimers that contain a strictly conserved tryrosine
that, in the presence of Cu2+ and O2, undergoes
autocatalytic posttranslational modification to generate the 2,4,5-trihydroxylphenylalanine
quinone (TPQ) cofactor.[10−12] In addition to the active site
Cu2+ binding site, some but not all CuAOs also contain
one or two peripheral metal sites.[13] CuAO
catalysis proceeds via a classical ping-pong mechanism with two half-reactions,
reductive and oxidative (Scheme ). The reductive half-reaction (Scheme , steps 1–3) has been well characterized
for a number of CuAOs. Cu2+-TPQOX (1) reacts with a primary amine to form a substrate Schiff base (2, TPQSSB). A conserved aspartate residue acts
as a catalytic base (Asp383 in ECAO) to facilitate proton abstraction
to form the product Schiff base (2 → 3, TPQPSB). Hydrolysis of TPQPSB (3) releases the aldehyde product, generating the aminoquinol (4, TPQAMQ).[14−18] Studies of the oxidative half-reaction are more challenging, but
two mechanisms have been proposed, inner sphere and outer sphere electron
transfer mechanisms.[19] It has been demonstrated
that Cu2+-TPQAMQ (4) exists in
equilibrium with Cu+-TPQSQ (semiquinone) (5).[20] The equilibrium (4 ↔ 5) for this interconversion (disproportionation
reaction) depends on the enzyme source, pH, and temperature.[21,22] In the inner sphere electron transfer mechanism, O2 binds
Cu+ in the Cu+-TPQSQ couple and is
reduced to superoxide (O2•–),[23−26] consistent with the well-documented physiological redox active role
for Cu2+/Cu+.[19,27,28] However, in the outer sphere electron transfer mechanism,
O2 binds to a hydrophobic pocket proximate to TPQAMQ and is reduced by TPQAMQ to O2•–.[29,30] Although the first electron transfer to
O2 is different in the two mechanisms, ultimately the Cu2+-hydroperoxide and iminoquinone (6, TPQIMQ) are generated. Hydrolysis of the TPQIMQ intermediate
releases ammonium and H2O2 and regenerates state 1.
Scheme 1
Proposed Catalytic Mechanism of CuAO, a Reductive
Half-Reaction (1 → 3) and an Oxidative
Half-Reaction
(inner sphere 5 → 6, outer sphere 4 → 6)
The highest turnover rates (kcat) are
observed in plant CuAOs, which display considerable amounts of 5 (≈80%) in the oxidative half-reaction.[20,21,23,26] Non-plant eukaryotic CuAOs, such as Hansenula polymorpha amine oxidase (HPAO), exhibit the lowest kcat values and negligible amounts of 5.[29,30] Experiments performed by Shepard et al.[31] provided evidence of the redox role of copper in the form of 5 in the bacterial Arthrobacter globiformis amine oxidase (AGAO); however, this has not been established in Escherichia coli amine oxidase (ECAO), another bacterial
CuAO.Although the mode of O2 activation differs
among CuAOs,
it occurs in a deeply buried active site. The timely and specific
delivery of O2 through the protein matrix to these buried
active sites has been an active area of study.[32−37] Xenon complexes and in silico studies have suggested
that molecular oxygen migration follows preferred routes and have
identified a conserved β-sandwich as the likely major pathway
for oxygen entry (Figure b, pathway 1).[32,38−40] Removing Ca2+ from the peripheral sites located at the surface of the
protein (Figure a)
near the opening of the β-sandwich results in a significant
decrease in enzyme activity.[13] In the work
presented here, we show that a single point mutation in ECAO at the
surface site interferes with TPQ biogenesis, which can be restored
by introducing a second mutation within a hydrophobic channel previously
identified as a putative oxygen delivery pathway. We also demonstrate
that the buried metal is required for full-length protein expression.
Figure 1
Overview
of important structural features of ECAO (Protein Data
Bank entry 1DYU). (a) The peripheral surface and buried metal binding sites (left)
and the active site (right) are magnified. (b) ECAO monomer showing
potential oxygen entry pathways (dashed lines) based on xenon binding
sites and residues targeted for mutagenesis (blue sticks). TPQ, copper,
and calcium ligands are shown as sticks colored by element. Copper
and calcium ions are shown as bronze and magenta spheres, respectively.
Water molecules are shown as red spheres, and xenons as green spheres.
Overview
of important structural features of ECAO (Protein Data
Bank entry 1DYU). (a) The peripheral surface and buried metal binding sites (left)
and the active site (right) are magnified. (b) ECAO monomer showing
potential oxygen entry pathways (dashed lines) based on xenon binding
sites and residues targeted for mutagenesis (blue sticks). TPQ, copper,
and calcium ligands are shown as sticks colored by element. Copper
and calcium ions are shown as bronze and magenta spheres, respectively.
Water molecules are shown as red spheres, and xenons as green spheres.
Methods
Mutagenesis, Expression,
and Purification of ECAO
Plasmid
pKKecao[16] was used as the template for
site-directed mutagenesis using a QuikChange protocol with KOD DNA
polymerase[41] to generate the following
single-mutation constructs where each plasmid identifies the mutation
introduced: buried metal site, pKKD533N and pKKD678N; surface site,
pKKE672K, pKKD670N, and pKKE573Q; and hydrophobic channel, pKKI342F.
An additional site-directed mutagenesis step was performed using pKKE573Q
as a template to generate the double mutation pKKE573Q/X (where X
is a hydrophobic channel mutation V640F/L/A, I342F/W, V345L/A, or
V536L or an active site mutation M699L/A/V or E490Q/I/A). Each variant
was confirmed by DNA sequencing.Wild-type ECAO (WTECAO) and
mutational variant proteins were prepared from XL-1 blue cells transformed
with the appropriate plasmid. Single colonies were used to inoculate
5 mL of 2YT medium with 100 μg/mL disodium carbenicillin and
grown at 37 °C while being shaken at 220 rpm for 16 h. Large
scale cultures of 500 mL of prewarmed 2YT medium with carbenicillin
and 50 μM CuSO4 in 2 L baffled flasks were inoculated
with 1 mL of the starter culture. Following incubation at 37 °C
and 220 rpm, when the OD600 reached 0.6–0.8 isopropyl
β-d-1-thiogalactopyranoside was added to a final concentration
of 1 mM and incubation continued for 6 h. Cells were harvested and
lysed, and ECAO was purified as previously described.[13] The gravimetrically derived correction factor of 0.76 was
used to determine protein concentration based on its absorbance at
280 nm (ε280 = 2.1 × 105 M–1 cm–1).[42] The molecular
masses of WTECAO and ECAO variants were determined by mass spectrometry
in the Astbury Centre for Structural Molecular Biology of the University
of Leeds.
Ultraviolet–Visible (UV–vis) Spectroscopy
A Shimadzu UV2401 PC spectrophotometer equipped with a temperature-controlled
cell holder was used to record CuAO spectra. To detect TPQ, spectra
were recorded over a range of 280–700 nm. Quantitative analysis
of the TPQ content per dimer was achieved by titrating with 2-hydrazinopyridine
(2-HP) as previously described.[13,43] Typically, 6–12
μM enzyme in 100 mM sodium phosphate (pH 7.0) was titrated by
stepwise addition of 0.1–1 molar equivalent of 2-HP. At each
titration step, the reaction was allowed to proceed until no further
absorbance change was detectable.
Enzyme Activity Assays
Enzyme activity was determined
as described previously.[13] Briefly, 20
μL of 0.2 μM purified enzyme was added to 980 μL
of assay buffer [100 mM sodium phosphate (pH 7.0), 0.58 mM 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic
acid) (ABTS), and 15 units mL–1 horseradish peroxidase
(HRP)], and the reaction progress was recorded at 410 nm using a Cary
50 spectrophotometer (Varian). Kinetic parameters, KM(amine), and kcat for β-phenylethylamine
(β-PEA) were calculated by fitting the initial rates (micromoles
per minute per milligram) using Origin Pro 7.5.To determine
O2 kinetic parameters, nitrogen gas was used to displace
O2 in buffers, solutions, and enzyme samples. N2 was passed over the headspace present in airtight glass vessels
containing 2 mL of 0.2 μM protein. The assay buffer [100 mM
sodium phosphate and 25 μM β-PEA (pH 7.0)] was degassed,
and N2 was bubbled directly into the solution continuously
while it was being stirred. A Hansatech Oxygraph system (Hansatech
Instruments Ltd.) was assembled, and the electrode was calibrated
according to the manufacturer’s instructions. Then, 980 μL
of assay buffer was transferred to the Oxygraph glass reaction vessel
from the N2-saturated buffer using an airtight Hamilton
syringe and allowed to reach a baseline. Following this, 20 μL
of O2-free enzyme was added and the rate of O2 consumption was recorded. Varying concentrations of O2 were obtained by mixing different ratios of oxygen-saturated and
nitrogen-saturated assay buffer. The data were used to calculate the
steady-state kinetic parameters, KM(oxygen), and kcat for O2 by fitting
the data to the Michaelis–Menten equation using Origin Pro
7.5.
Anaerobic Reduction of ECAO
Solutions were made anaerobic
by degassing and passing a steady stream of N2 into them
while they were being stirred for 1 h. Protein solutions were not
stirred, and anaerobiosis was achieved by passing N2 into
the headspace, allowing gas exchange without bubbling directly into
the solution. A 240 μL aliquot of protein with the active enzyme
at a concentration of 100 μM (based on TPQ content) was added
to a 1 mL quartz cuvette with a ground glass joint sealed with a rubber
septum. The substrate-reduced enzyme was prepared by adding a 5-fold
molar excess of anaerobic β-PEA. Spectra were recorded until
no further changes were observed. Subsequently, O2 was
allowed to enter the cuvette by diffusion, and spectra were recorded
until no further change was observed. To determine the 5 content (Scheme ), a 16-fold molar excess of anaerobic KCN was added to anaerobically
β-PEA-reduced enzyme and spectra were recorded until no further
changes were observed.[44]The level
of 5 was calculated using eq
EDTA Treatment
All plasticware was
soaked in 100 mM
EDTA (pH 8.0) for 30 min and thoroughly rinsed in Chelex-treated water.
Chelex-treated water and buffers were prepared by passing the solutions
through a Chelex-100 (resin, mesh 100–200, Bio-Rad) column.
EDTA (pH 7.0) was added to a final concentration 1000-fold higher
than that of ECAO and incubated for 2 h. Excess EDTA was removed by
three buffer exchange steps using a metal-free centrifugal filter
device. Specific activity assays were performed at 25 °C in assay
buffers supplemented with 3 mM CaCl2 and 0.05 mM CuSO4.
X-ray Crystallographic Structure Analysis
Crystals
of WTECAO and its variants were grown as previously described.[16] In brief, the crystals were grown by the sitting
drop vapor diffusion method in 100 mM HEPES (pH 6.9–7.2) and
sodium citrate (1.10–1.35 M). A 3–5 μL aliquot
of a protein sample (6–12 mg/mL) was mixed with the same volume
of mother liquor. Prior to data collection, the drop solution was
gradually exchanged with the well solution containing 5% (v/v) increments
of glycerol to a final concentration of 30–45% (v/v) glycerol
and subsequently flash-frozen in liquid nitrogen for X-ray data collection.
Data were collected at Diamond Light Source (beamline I02). As observed
with previous ECAO crystals, the proteins crystallized in space group P212121. The data were
processed using XDS[45] and SCALA.[46] The CCP4 suite[47] was
used for further processing, model building, and refinement. 1DYU,[16] an isomorphous WTECAO structure, was used as a starting
model. Refinement and model building were performed using Refmac5[48] and COOT,[49] respectively.
Rigid body refinement was performed to optimize the orientation of
the starting model. COOT was used to build the missing side chains
and add the metals and water molecules where appropriate. Successive
rounds of positional refinement and rebuilding generated the final
model. Details of crystal parameter, data collection, and refinement
statistics are listed in Table S1.
Results
Mutations
at the Buried Metal Site
Two residues coordinating
the buried Ca2+ were mutated to asparagine (D553N and D678N).
No full-length ECAO was detected in periplasmic extracts even when
the growth conditions were supplemented with increasing concentrations
of Ca2+ and no ECAO enzyme activity could be measured (Figures S1 and S2). These results were unexpected
but suggest that Ca2+ in the buried binding site is required
for the effective folding and/or stability of ECAO.
Mutations at
the Surface Metal Site
In contrast to
the buried metal site, which shows a preference for binding a divalent
cation in all CuAOs, with the exception of H. polymorpha CuAO (HPAO),[6,41,50−56] the surface metal site is promiscuous and binds whatever mono- or
divalent cation is available.[41] Site-directed
mutagenesis of residues (E573, D670, and E672) comprising the surface
Ca2+ binding site surprisingly resulted in significantly
reduced CuAO activity, even though the expression levels of these
mutants were similar to that of WTECAO and the site is some 32 Å
from the active site (Figure ). The reduction in activity followed the trend D670N <
E672K ≪ E573Q, with mutation E573Q showing the least activity
(Figure ).
Figure 2
Activity profile
of WTECAO and surface metal site mutants (D670N,
E672K, and E573Q) where n = 3.
Activity profile
of WTECAO and surface metal site mutants (D670N,
E672K, and E573Q) where n = 3.
Effects of Surface Mutation E573Q on TPQ Biogenesis and Catalysis
The E573Q mutant lacked the distinct coloration afforded by the
chromophore properties of TPQ. Although ESI-MS suggested the absence
of TPQ, low levels were detected by UV–vis spectroscopy (Figure ) and confirmed by
2-HP titrations [∼16% of the WTECAO TPQ content (Figure , inset)]. Kinetic studies
demonstrated a KM(amine) of 1.1 μM
and a KM(O of 16.6 μM,
consistent with that of the wild type; however, ≥88-fold reductions
in both kcat(amine) and kcat(O were observed (Table ). Kinetic studies of E573Q demonstrated
the observed activity was not due to contamination by wild-type ECAO
expression in the host cells, as Y466F, carrying a mutation of the
active site tyrosine that is incapable of undergoing processing to
form TPQ, showed no activity (Figure ).[17]
Figure 3
UV–vis spectra
of WTECAO, I342F, I342F/E573Q, and E573Q
at 10 mg/mL measured in 20 mM Tris (pH 7.0). Inset 1 shows the TPQ
content in each protein sample measured by titrating TPQ with 2-HP.
Table 1
Kinetic Parameters
for the Reaction
with β-PEA and O2, Measured in 100 mM Sodium Phosphate
(pH 7.0)
WTECAO
I342F
E573Q/I342F
E573Q
β-PEA
kcat (s–1)
14.6 ± 0.5
16.5 ± 0.6
0.67 ± 0.004
0.15 ± 0.0007
KM (μM)
1.3 ± 0.2
1.4 ± 0.2
1.4 ± 0.03
1.1 ± 0.21
kcat/KM (μM–1 s–1)
11 ± 1.8
12 ± 1.7
0.48 ± 0.021
0.14 ± 0.026
relative activity (%)
100
113
4.6
1
O2
kcat (s–1)
43.2 ± 1
59.6 ± 5.4
1.67 ± 0.09
0.49 ± 0.02
KM (μM)
25.2 ± 3.8
24.1 ± 2.7
20.7 ± 2.2
16.6 ± 2
kcat/KM (μM–1 s–1)
1.7 ± 0.26
2.8 ± 0.37
0.81 ± 0.1
0.3 ± 0.04
relative activity (%)
100
138
3.9
1.1
UV–vis spectra
of WTECAO, I342F, I342F/E573Q, and E573Q
at 10 mg/mL measured in 20 mM Tris (pH 7.0). Inset 1 shows the TPQ
content in each protein sample measured by titrating TPQ with 2-HP.
Rescue of E573Q by Suppressor Mutations
Attempts to
reconstitute activity in the E573Q mutant by saturating with oxygen,
incubating at 37 °C (24 h), adding Ca2+ (1 mM), prolonging
the incubation time (>1 year at 4 °C), or combinations of
these
had no effect on TPQ formation or enzyme activity. We therefore attempted
to rescue the E573Q phenotype by introducing second site mutations
into the active site (M699L/A/V and E490Q/I/A) (Figures S3 and S4) and in the hydrophobic channel proposed
to be the route of oxygen entry (V640F/L/A, I342F/W/D, V345L/A/F,
V536L/A/F, and Y468A) (Figure S5).[41] The only mutant that showed any level of rescue
of the E573Q phenotype was the I342F mutant. Unfortunately, it did
not prove to be possible to produce protein from the I342W or I342D
variant.
Effects of a Suppressor Mutation, I342F, on TPQ Biogenesis and
Catalysis in E573Q
The I342F mutation resulted in partial
suppression of the effects of the E573Q mutation. Unlike E573Q, the
double mutant, I342F/E573Q, was pink in color, indicating the presence
of substantial TPQ. The UV–vis spectroscopy data (TPQ content
and 2HP titrations) showed that the I342F mutation partially suppressed
the effects of the E573Q mutation, by increasing the TPQ content to
∼60% of the wild-type (WT) TPQ content (Figure ). Interestingly, however, the kinetic data
showed that the turnover rate of I342F/E573Q with respect to both
substrates was only ∼4% of that of the WT (Table ). The measured KM(amine) (1.4 μM) and KM(O (20.7 μM) were consistent with those of WTECAO
(Table ). The I342F
single mutant was similar to the wild type with a KM(amine) of 1.4 μM, a KM(O of 24.1 μM, a kcat(amine) of 16.5 s–1, and a kcat(O of 59.6 s–1 (Table ). The UV–vis spectrum of I342F showed
increased absorbance in the 350 nm region relative to that of the
WT and a shift from 480 to 470 nm; together, these changes suggest
that there are microenvironmental effects that perturb the electronic
structure of the TPQ (Figure ).
Detecting Differences in the Active Sites
of I342F, WT, I342F/E573Q,
and E573Q
2HP titrations determined 1.5 TPQs per dimer in
WTECAO, 1.6 TPQs per dimer in I342F, 1 TPQ per dimer in I342F/E573Q,
and 0.2 TPQ per dimer in E573Q (Figure , inset); 1.5 TPQ molecules instead of 2 were detected
in WTECAO most probably because of the inefficient processing of the
highly conserved tyrosine residue to form TPQ.[43,57] It is possible that the shoulder at 350 nm is a result of inefficient
processing of the precursor Y466 such that TPQ biogenesis is stalled
at the Cu(II)-tyrosinate intermediate that has a λmax of 350 nm.[58] Upon reaction of E573Q and
I342F/E573Q with molar equivalents of 2HP, the azo form of adduct
I and adduct II[70] were immediately observed
as the UV–vis spectra show two peaks at 416 and 520 nm (Figure ).[59] A full conversion from the azo form to adduct II was observed
with prolonged incubation at room temperature in I342F/E573Q.[59] By contrast, for WTECAO and I342F, only the
hydrazone form of adduct I was detected. No spectral change was observed
for Y466F as expected (Figure ).
Figure 4
Effects of reacting 10 mg/mL WTECAO, I342F, I342F/E573Q, or E573Q
with a 10-fold molar excess of 2-HP in 100 mM sodium phosphate (pH
7.0) at 25 °C.
Effects of reacting 10 mg/mL WTECAO, I342F, I342F/E573Q, or E573Q
with a 10-fold molar excess of 2-HP in 100 mM sodium phosphate (pH
7.0) at 25 °C.A shift from the hydrazone
to azo form of adduct I was observed
only when WT–2HP and I342F–2HP complexes were heated
(Figure ). At 50 °C,
the λmax shifts from 432 to 416 nm with a further
increase in absorbance (Figure ). A significant increase in adduct II was also observed at
50 °C (Figure ). The increase in absorbance associated with the conversion of hydrazone
adduct I (432 nm) to azo adduct I (416 nm) in WT and I342F suggests
the molar extinction coefficient for the azo form is higher than that
of the hydrazone form, consistent with previous reports (Figure ).[59]
Figure 5
Effect of temperature on the hydrazone form of adduct I in (a)
WTECAO and (b) I342F.
Effect of temperature on the hydrazone form of adduct I in (a)
WTECAO and (b) I342F.The formation of adduct II has been associated with active
site
mutations that alter the hydrogen-bonding network within the active
site, resulting in greater flexibility of the TPQ–2HP complex.
An increase in temperature may also induce large movements that enable
the TPQ–2HP complex to coordinate the active site Cu2+.[59] In this case, the data provide an
indication that mutations E573Q and E573Q/I342F may influence the
active site to promote formation of adduct II in a proportion of the
molecules at low temperatures (Figure ), but further characterization would be required to
confirm this.
Effects of the Long-Range Mutations on the
Catalytic Intermediates
The levels of 5 (Scheme ), in the absence
of oxygen, were measured
in the presence and absence of CN– at 25 °C.
Upon reaction of WT with β-PEA under anaerobic conditions, features
that are characteristic of 5,[21,26,60] i.e., three peaks at 350, 438, and 467 nm,
were observed (Figure ). The apparent level of 5 obtained using eq is 34.3% as reported in ref (61). In the absence of CN–, the levels of 5 (∼46.7 μM)
were similar to those detected in the presence of CN– (∼50 μM), suggesting that 5 is the major
intermediate in the ECAO catalytic pathway.
Figure 6
Anaerobic reduction of
WTECAO with β-PEA at 25 °C in
the absence (TPQred) and presence of cyanide (TPQred+KCN): (a) UV–vis spectra and (b) difference spectra.
Anaerobic reduction of
WTECAO with β-PEA at 25 °C in
the absence (TPQred) and presence of cyanide (TPQred+KCN): (a) UV–vis spectra and (b) difference spectra.Removal of Ca2+ from the surface metal
site resulted
in a 37-fold decrease in the specific activity of the protein, consistent
with previous work[13] (Table ). Incubating the EDTA-treated
WT enzyme with 3 mM CaCl2 (1000-fold excess) resulted in
an increase in the specific activity to half that of the WT (Table ). Analysis of metal
content by Smith et al.[13] showed that WTECAO
contained 1.05 ± 0.01 coppers per subunit and that following
incubation with EDTA it retained 0.95 ± 0.05 copper per subunit,
demonstrating that the deeply buried active site copper is tightly
bound and not accessible to EDTA, which suggests that a lack of recovery
of enzyme activity is not due to the loss of the active site copper.[13]
Table 2
Specific Activities
(micromoles per
minute per milligram) of WTECAO with and without EDTA Treatment or
Ca2+ and Cu2+ Supplementation
WTECAO
8.6 ± 0.4
EDTA-treated ECAO
0.23 ± 0.04
EDTA-treated ECAO with 3
mM CaCl2
4.4 ± 0.32
EDTA-treated ECAO with 3
mM CaCl2 and 0.05 μM CuSO4
1.7 ± 0.4
WTECAO with 3 mM CaCl2 and 0.05 μM
CuSO4
4.6 ± 0.7
EDTA-treated WT, EDTA-treated WT with 3 mM CaCl2, and
WT were reacted with β-PEA under anaerobic conditions. At equal
concentrations of 1 (Figure b), a significant difference in the levels
of 5 was observed in these samples (Figure ). The difference spectra were
obtained by subtracting the initial state of the enzyme (1) (Figure c). On
the basis of the ε468 for TPQSQ (4500
M–1 cm–1) reported for the A. globiformis enzyme,[25] 1.3
and 2.7 μM 6 were detected in EDTA-treated WT with
3 mM CaCl2 and WT, respectively. The levels of 5 formed in these samples correlate with the observed specific activities.
EDTA-treated WT with 3 mM CaCl2 displayed 50% of the WT
level of 5 and exhibited ∼50% of WT activity (Figure ). The amount of 5 in EDTA-treated WT was significantly smaller.
Figure 7
Effect of EDTA
and Ca2+ treatment on the Cu+-TPQSQ and Cu2+-TPQAMQ equilibrium
in WTECAO at 25 °C: (a) TPQ content, (b) Cu+-TPQSQ content, and (c) difference spectra of Cu+-TPQSQ.
Effect of EDTA
and Ca2+ treatment on the Cu+-TPQSQ and Cu2+-TPQAMQ equilibrium
in WTECAO at 25 °C: (a) TPQ content, (b) Cu+-TPQSQ content, and (c) difference spectra of Cu+-TPQSQ.To further investigate the differences
in the turnover rate and
active site environments, the reductive half-reaction for each enzyme
was monitored under anaerobic conditions. Before reaction, the UV–vis
spectra of WT, I342F, and E573Q/I342F displayed a λmax at 480 nm confirming the presence of TPQox (1) (Figure ). Characteristic
features of 5 were observed for WT and I342F (Figure ). The spectra for
both proteins displayed peaks at 438 and 467 nm and a small shoulder
at 357 nm, features that have been previously assigned to 5.[21,26] Difference spectra for WT and I342F obtained
by subtracting the initial state of TPQ from the reduced state showed
the presence of both 4 (310 nm) and 5 (310,
438, and 467 nm) as previously observed for PSAO and AGAO.[21,26,60]
Figure 8
Spectroscopic reactivity of anaerobically
substrate-reduced (a,
c, and e) WTECAO and (b, d, and f) I342F at 25 °C. (a and b)
Reductive half-reactions, (c and d) difference spectra for the reductive
half-reactions, and (e and f) oxidative half-reactions. Spectral changes
were recorded every 0.1 s; the red spectrum was measured at 0.3 s,
the purple spectrum at 4.1 s, the green spectrum at 6.7 s, and the
blue spectrum at 14.3 s.
Spectroscopic reactivity of anaerobically
substrate-reduced (a,
c, and e) WTECAO and (b, d, and f) I342F at 25 °C. (a and b)
Reductive half-reactions, (c and d) difference spectra for the reductive
half-reactions, and (e and f) oxidative half-reactions. Spectral changes
were recorded every 0.1 s; the red spectrum was measured at 0.3 s,
the purple spectrum at 4.1 s, the green spectrum at 6.7 s, and the
blue spectrum at 14.3 s.At TPQ concentrations similar to that of WT, the difference
spectrum
of I342F/E573Q on reduction with β-PEA under N2 saturating
conditions showed only the characteristic features of 4, a peak, at 310 nm (Figure ). Similar treatment of E573Q also resulted in only 4, the intermediate observed in substrate-reduced HPAO, BSAO,
Co2+-AGAO, and Ni2+-AGAO (Figure ).[22,30,62,63] Although different catalytic
species were observed, TPQ was successfully regenerated in all four
proteins: WT, I342F, I342F/E573Q, and E573Q (Figures and 9).
Figure 9
Spectroscopic
reactivity of anaerobically substrate-reduced (a,
c, and e) I342F/E573Q and (b, d, and f) E573Q at 25 °C. (a and
b) Reductive half-reactions, (c and d) difference spectra for the
reductive half-reactions, and (e and f) oxidative half-reactions.
Spectral changes were recorded every 0.1 s; the red spectrum was measured
at 3.3 s, the purple spectrum at 9.3 s, the green spectrum at 10.7
s, and the blue spectrum at 15.8 s.
Spectroscopic
reactivity of anaerobically substrate-reduced (a,
c, and e) I342F/E573Q and (b, d, and f) E573Q at 25 °C. (a and
b) Reductive half-reactions, (c and d) difference spectra for the
reductive half-reactions, and (e and f) oxidative half-reactions.
Spectral changes were recorded every 0.1 s; the red spectrum was measured
at 3.3 s, the purple spectrum at 9.3 s, the green spectrum at 10.7
s, and the blue spectrum at 15.8 s.
Crystal Structure Analysis
To understand the effects
of the mutations and in particular those of I342F in the background
of mutation E573Q, crystal structures of E573Q/I342F [Protein Data
Bank (PDB) entry 6GRR] and E573Q (PDB entry 6EZZ) were determined by X-ray crystallography and refined
to 1.7 and 1.8 Å, respectively. The data collection and processing
statistics are shown in Table S1. The mutant
structures showed a high level of structural similarity to WTECAO,
with the most significant differences occurring at the active site
and mutation sites.No TPQ was observed in the structure of
either mutant; rather, the 2Fo – Fc maps showed well-defined electron density
corresponding to a tyrosine residue directly coordinated to the copper
as observed in the early stages of TPQ biogenesis (Figure ).[11] There is some extra electron density at the C2 and O4 positions
of Y466 in both structures (Figure a,b), and this is more evident in I342F/E573Q in the Fo – Fc map
(green mesh) in Figure b. This was expected for E573Q as the biochemical and mass
spectrometry studies did not detect significant levels of TPQ. However,
this was not the case with I342F/E573Q where 60% of the WTECAO TPQ
content was observed. This may indicate substantial flexibility or
preferential crystallization of the precursor form. Collecting data
at room temperature may provide more information with regard to TPQ
flexibility.[64]
Figure 10
Electron density maps
of the (a) E573Q (PDB entry 6EZZ) and (b) I342F/E573Q
(PDB entry 6GRR) active sites. The 2Fo – Fc (gray mesh) and Fo – Fc (green mesh) maps are contoured
at 1 and 3 rmsd, respectively.
Electron density maps
of the (a) E573Q (PDB entry 6EZZ) and (b) I342F/E573Q
(PDB entry 6GRR) active sites. The 2Fo – Fc (gray mesh) and Fo – Fc (green mesh) maps are contoured
at 1 and 3 rmsd, respectively.In addition to the lack of the TPQ, subtle changes were observed
in the active sites of both I342F/E573Q and E573Q. Comparison between
these two variants and the 1DYU (off-copper)[16] WTECAO active
site (Figure a,b)
showed that H526, D383, and M699 each displayed positional flexibility.
In particular, C3 of M699 is rotated ∼45° toward the C3
position of Y466 (Figure a,b), where oxygen is proposed to attack the aromatic ring
during the first step of TPQ biogenesis to yield dopaquinone.[11] Superimposing the E573Q and I342F/E573Q structures
onto the 1OAC (on-copper) WTECAO[55] structure showed
that for both variants M699 still displays a different conformation
and D383 adopts a conformation similar to that observed when TPQ is
present in its “on-copper” conformation[55] (Figure c,d).
Figure 11
Superposition of the E573Q (yellow) and I342F/E573Q (magenta) active
sites onto (a and b) WTECAO, where TPQ is in the “off-copper”
conformation (PDB entry 1DYU) (cyan), and (c and d) WTECAO, where TPQ is in the
“on-copper” conformation (PDB entry 1OAC) (green).
Superposition of the E573Q (yellow) and I342F/E573Q (magenta) active
sites onto (a and b) WTECAO, where TPQ is in the “off-copper”
conformation (PDB entry 1DYU) (cyan), and (c and d) WTECAO, where TPQ is in the
“on-copper” conformation (PDB entry 1OAC) (green).Exterior to the active site, while
the 1DYU WTECAO
structure shows differences in
the surface metal (calcium ion) site for the two crystallographically
independent subunits of ECAO, when residue 573 is mutated from glutamate
to glutamine the ECAO loses its ability to bind a metal ion at this
site (Figure ).
In subunit A of both E573Q and I342F/E573Q, the calcium ion is replaced
by a water molecule; however, in subunit B, no water molecule is observed
(Figure a,b). The
lack of a surface metal site in E573Q and I342F/E573Q results in a
significant increase in flexibility as indicated by the B factor values (Figure d) and poorly defined side-chain electron density in loops
569–574 and 667–673. In contrast to E573Q, mutation
I342F has no obvious effects on the overall structure of the enzyme.
F342 has fewer rotational degrees of freedom than isoleucine does
and fits perfectly in the hydrophobic channel partially stacking with
W472 (Figure ).
Figure 12
Structures
of peripheral surface metal sites of (a) E573Q (yellow),
(b) I342F/E573Q (magenta), and (c) WTECAO (PDB entry 1DYU) (cyan). (d) Structures
of subunit A with B factors for individual atoms
represented by a ribbon structure in which the ribbon thickness indicates
the magnitude of the B factor; thin indicates low B factors, and thick indicates high B factors.
Bound calcium ions are represented as green spheres, whereas in panel
d, the surface and buried calcium sites are represented by the top
and bottom green spheres, respectively.
Figure 13
Structure of the putative oxygen entry channel. (a) The 2Fo – Fc map
is contoured at 1 rmsd showing the electron density of residues in
the hydrophobic channel as a gray mesh: E573Q (yellow) and I342F/E573Q
(magenta). (b) View down the channel highlighting residues mutated
in ref (41) and in
this study: WTECAO (green) and I342F/E573Q (magenta).
Structures
of peripheral surface metal sites of (a) E573Q (yellow),
(b) I342F/E573Q (magenta), and (c) WTECAO (PDB entry 1DYU) (cyan). (d) Structures
of subunit A with B factors for individual atoms
represented by a ribbon structure in which the ribbon thickness indicates
the magnitude of the B factor; thin indicates low B factors, and thick indicates high B factors.
Bound calcium ions are represented as green spheres, whereas in panel
d, the surface and buried calcium sites are represented by the top
and bottom green spheres, respectively.Structure of the putative oxygen entry channel. (a) The 2Fo – Fc map
is contoured at 1 rmsd showing the electron density of residues in
the hydrophobic channel as a gray mesh: E573Q (yellow) and I342F/E573Q
(magenta). (b) View down the channel highlighting residues mutated
in ref (41) and in
this study: WTECAO (green) and I342F/E573Q (magenta).
Discussion
The E573Q mutation, some
32 Å from the active site, has a
major long-range conformational effect on the formation of TPQ and
catalytic turnover. Residue 573 is located near the opening of the
hydrophobic channel identified as the putative O2 delivery
pathway. Although low levels of TPQ were detected for this variant
(16% WT TPQ), attempts to drive TPQ biogenesis under O2 saturating conditions failed, demonstrating the inability of the
mutant to activate O2 for TPQ formation. A comparison of
the structure of WTECAO with E573Q shows only minor changes at the
active site and surface mutation site. The lack of efficient TPQ processing
in E573Q may be due to (a) a change in the geometry and/or bond lengths
in the copper primary coordination sphere, (b) an inability to form
the ligand to metal charge transfer (LMCT) complex required for O2 activation, and/or (c) the inability of O2 to
enter the active site or adopt a productive position due to alterations
in ECAO dynamics associated with the preferred O2 entry
channel.The first two suggestions can be dismissed as the E573Q
copper
tetrahedral geometry and the distances between copper and tyrosine
are identical to those reported for other CuAO precursor states,[65,66] and the distance between copper and histidine is similar to that
of WTECAO (Figure S6).[16] However, fine-tuning an optimized structure of the copper
coordination sphere(s) is known to be important for both cofactor
biogenesis and catalysis.[13,66,67] Potentially subtle changes, beyond the detection limit of crystallography,
in the positioning of copper, the three histidines, and key side chains[60] may have conceivably stalled biogenesis. Currently,
during TPQ biogenesis in ECAO, there are no reported data to suggest
the formation of an LMCT intermediate, a species successfully observed
and characterized in HPAO.[58] Furthermore,
attempts to detect a 350 nm Cu(II)–tyrosinate complex spectrophotometrically,
even in the presence of a saturating level of O2, were
unsuccessful, and as no such complex has been observed in AGAO,[11] it may not occur in any bacterial CuAO.The proposed rate-limiting step in biogenesis is the formation
of a peroxy intermediate that occurs as a result of direct electron
transfer from the metal-coordinating tyrosinate complex to the bound
O2.[68] It is possible that changes
in active site flexibility or dynamic motions, demonstrated by the
preferred formation of a copper-coordinated TPQ–2HP species
(adduct II) in E573Q, inhibit the accessibility of O2 proximal
to precursor Y466 where some effect of a steric/electronic clash,
on O2 activation, could disfavor formation of a peroxy-Cu(II)-bound
intermediate. TPQ biogenesis has been shown to be a dynamic process
requiring rotation of the precursor tyrosine and surrounding side
chains during the reaction.[11] In the crystal
structures of both E573Q and I342F/E573Q, the hydrophobic channel
remains open; however, because of the bulky nature of phenyalanine
at position 342 the channel is narrower in I342F/E573Q (Figure b) than in E573Q,
although O2 delivery is apparently more efficient in the
former based on TPQ formation. Therefore, protein dynamics are likely
to play a key role in the improved delivery of O2 to the
active site for TPQ biogenesis.To probe oxygen entry and/or
delivery, multiple residues were mutated
in the β-sandwich funnel (hydrophobic channel).[41] In the E573Q background, the addition of the I342F mutation
led to a partial rescue of TPQ biogenesis, reaching 60% of that of
WT. Associating the reactivation of TPQ biogenesis in the double mutant
with an improvement in the delivery of O2 to the active
site is tempting as I342 corresponds to a “hinge” region
connecting two critical regions of the putative hydrophobic oxygen
entry channel. However, there is no direct link between residues E573
and I342 and the active site residues required for TPQ biogenesis.
Possible reasons for the recovery of TPQ biogenesis in I342F/E573Q
are that the I342F mutation has physically levered open the hydrophobic
channel by increasing the steric bulk at the hinge region to promote
access of O2 to the active site or it counteracts the dynamic
effects imposed by the E573Q mutation allowing activation of O2 by the LMCT complex. Exposing E573Q that had been held under
N2 saturating conditions to air led to the reoxidation
of the small amounts of TPQ present, indicating that access of O2 to the active site is not entirely blocked (Figure d).While xenon complex
crystal structures and in silico experiments identified a
major putative O2 entry pathway, mutagenesis experiments
designed to block individual pathways have had little effect on the
overall kcat/KM, implying that O2 uses multiple dynamic routes to reach
the active site.[69] One possibility is that
two different O2 pathways are employed for TPQ biogenesis
and the catalysis of O2 reduction.There is no structural
evidence of the effects afforded by the
I342F mutation; however, inhibition studies using 2HP highlighted
differences in the active sites of I342F/E573Q (adduct II) and WT
(adduct I), suggesting increased active site flexibility in the double
mutant (Figure ).
Adduct II is formed when the TPQ–2HP complex rearranges to
coordinate the active site Cu2+, suggesting increased flexibility
in the active site.[59] The formation of
adduct II has previously been observed with active site mutations
Y381F and Y369F.[59,70] This implies that TPQ in I342F/E573Q
preferentially adopts an “on-copper” conformation unlike
that in WTECAO and I342F.Although TPQ biogenesis is reactivated
in E573Q/I342F, introducing
the I342F mutation does not lead to a corresponding enhancement of
the catalytic activity of E573Q. To understand the effect of E573Q
on catalysis, the catalytic reaction was followed under anaerobic
conditions. Reducing WTECAO, I342F, I342F/E573Q, and E573Q with β-PEA
under anaerobic conditions revealed an interesting and distinct difference
in catalytic intermediates formed over the course of the reaction.In WTECAO and I342F, the characteristic features of 5 were observed (Figure ) and the difference spectra showed both 4 (310 nm)
and 5 (λmax, 357, 438, and 468 nm) as
observed for LSAO, PSAO, AGAO, and APAO, which are all CuAOs that
use the inner sphere electron transfer mechanism to activate O2.[21,23,25,26,71,72] In such CuAOs, the intermediates exist in an equilibrium that favors 5 and exhibit fast turnover rates as the electron transfer
rate between Cu+ and O2 is greater than or equal
to the overall rate of turnover and thus is not the rate-limiting
step.[26,31] The ability to form 34% of the Cu+-TPQSQ (5), as previously reported, suggests
that ECAO uses the inner sphere electron transfer mechanism as reported
for AGAO, another bacterial CuAO.[25,31]For
E573Q and I342F/E573Q, the difference spectra showed only the
characteristic feature for 5 as observed with BSAO and
HPAO, CuAOs that use the outer sphere electron transfer mechanism.[29,30,63] The ability of a second sphere
residue to influence the equilibrium between 4 and 5 has been shown with HPAO.[22] Detecting
only 4 in E573Q and I342F/E573Q suggests a shift in the
equilibrium in favor of 5. The ∼100-fold decrease
in activity of E573Q can be explained by a change from the inner to
outer sphere electron transfer mechanism. If this is the case, the
data presented here represent the first report in CuAOs of a residue
distant from the active site affecting the properties of the redox
active metalloenzyme.In support of this, removal of Ca2+ by EDTA chelation
reduced activity significantly as well as the levels of intermediate 5. Addition of Ca2+ to the same sample partially
restored activity and increased 5 levels, confirming
that the peripheral metal sites play a role in regulating the equilibrium
that exists between 4 and 5. These data
also support the hypothesis that ECAO uses the inner sphere electron
transfer mechanism in the oxidative half-reaction and demonstrates
an allosteric role for Ca2+ sites. Mammalian CuAOs, BSAO,
VAP-1, and hDAO have been shown to have a surface metal binding site
similar to that of ECAO. It is possible that in mammalian systems,
control of Ca2+ availability may represent a method for
regulating the CuAO activity and thereby controlling the production
of H2O2 that can be important in cell signaling
but that, together with product aldehydes, can in excess be detrimental
to cells.E573Q affects the enzyme’s ability to form 5 interfering with the redox potential of the Cu2+/Cu+ couple such that reduction to Cu+ is disfavored.
This would suggest that the E573Q mutation results in a substantially
weakened ability to form the Cu+-tyrosyl radical intermediate
thus stalling TPQ biogenesis at the O2 activation stage
(D in Scheme ). The E573Q crystal structure supports this hypothesis as
Y466 interacts with the copper ion at a bond distance of 2.03 Å,
resembling the structures observed in the early stages of TPQ biogenesis
and suggesting that biogenesis is stalled after the deprotonation
of Y466. The improvement in TPQ biogenesis associated with the I342F
mutation may result from changes in the dynamic behavior of the enzyme.
These changes may be a result of improved structural stability associated
with the stacking interaction between W472 and F342 in I342F/E573Q.
It is still reasonable to associate this improvement in TPQ biogenesis
with improved delivery of O2 to the active site.
Scheme 2
Proposed
Mechanism for TPQ Biogenesis in Copper Amine Oxidases[73]
Conclusion
Through
a combination of biochemical and site-directed mutagenesis
studies, we have demonstrated a likely regulatory role for the surface
metal site in ECAO. Removing the surface site Ca2+ by chelation
or mutagenesis (E573Q) affects TPQ biogenesis and catalytic efficiency
in amine oxidation at the active site, some 32 Å away. This interferes
with the Cu2+/Cu+ couple and supports the proposal
of an inner sphere electron transfer mechanism in this enzyme. EPR
spectroscopy studies will provide more insight into the effects of
the E573Q mutation on the redox state of copper. The lack of obvious
structural differences in the crystal structures of the mutants and
WTECAO suggests a role for protein dynamics in transmitting the effects
of mutations that are 32 Å (E573Q) and 22 Å (I342F) from
the active site. Reactivation of TPQ biogenesis in I342F/E573Q could
be associated with improved delivery of O2 to the active
site. Further studies to understand the role of the surface site in
ECAO dynamics and delivery of O2 to the active site remain
an important goal.
Authors: Carrie M Wilmot; Colin G Saysell; Aidan Blessington; Danyl A Conn; Christian R Kurtis; Michael J McPherson; Peter F Knowles; Simon E V Phillips Journal: FEBS Lett Date: 2004-10-22 Impact factor: 4.124
Authors: Bryan J Johnson; Jordi Cohen; Richard W Welford; Arwen R Pearson; Klaus Schulten; Judith P Klinman; Carrie M Wilmot Journal: J Biol Chem Date: 2007-04-04 Impact factor: 5.157
Authors: P Dunkel; A Gelain; D Barlocco; N Haider; K Gyires; B Sperlágh; K Magyar; E Maccioni; A Fadda; P Mátyus Journal: Curr Med Chem Date: 2008 Impact factor: 4.530
Authors: Charles N Adelson; Esther M Johnston; Kimberly M Hilmer; Hope Watts; Somdatta Ghosh Dey; Doreen E Brown; Joan B Broderick; Eric M Shepard; David M Dooley; Edward I Solomon Journal: J Am Chem Soc Date: 2019-05-28 Impact factor: 15.419
Authors: Rebecca Schneider; Tobias A Engesser; Christian Näther; Ingo Krossing; Felix Tuczek Journal: Angew Chem Int Ed Engl Date: 2022-04-28 Impact factor: 16.823